Rheumatoid arthritis
A long-term condition in which the immune system attacks the lining of the joints by mistake, causing pain, swelling and stiffness.1 It often starts in the small joints of the hands and feet, usually on both sides of the body.2 There is no cure, but long-term medicines ease the symptoms and slow the disease down.1 Women get it more often than men, and with early treatment many people go months or years between flare-ups.1
Read more about Rheumatoid arthritisTrial-stage treatments and research studies you can join
Filters
- Tests nivolumab, alone or combined, for advanced cancers in people with autoimmune disorders
Tests nivolumab, alone or with other treatments, in adults with autoimmune disorders and advanced cancer.
Atlanta, United StatesAlso Baltimore, Bethesda, Birmingham, Boston, Chicago, City of Saint Peters, Columbus, Creve Coeur, …Age 18+ - Tests AZD0120 cell therapy in adults with systemic sclerosis, myositis or rheumatoid arthritis
Tests the safety of AZD0120 in adults with certain autoimmune diseases.
Ann Arbor, United StatesAlso Baltimore, Chapel Hill, Chicago, Duarte, Miami, New York, Seattle, Stanford, …Age 18 to 75 - Tests PTC844 against placebo in adults with active rheumatoid arthritis
Tests PTC844 against a placebo in adults with active rheumatoid arthritis.
Chandler, United StatesAlso Charlotte, Chicago, Cutler Bay, Fairfax, Flagstaff, Irving, Miami, New Port Richey, …Age 18 to 70 - Studies hip cup placement in hip replacement surgery using navigation
Tests a navigation system guiding hip cup placement in adults needing hip replacement.
Gainesville, United StatesAlso GastoniaAge 21+ - Tests NKX019, a cell therapy, in adults with immune-mediated diseases
Tests NKX019 cell therapy for systemic sclerosis, myositis, vasculitis, and rheumatoid arthritis.
Ann Arbor, United StatesAlso Charlotte, Dallas, Fairway, Hackensack, Los Angeles, Minneapolis, New York, Plantation, …Age 18 to 75 - Tests surovatamig, a new medicine, in adults with rheumatoid arthritis or lupus
Tests surovatamig's safety and how the body handles it in adults with arthritis or lupus.
Allen, United StatesAlso Birmingham, Fullerton, Mesquite, Plantation, St LouisAge 18 to 65 - Tests ELV001 added to treatment for active rheumatoid arthritis not controlled by other drugs
Tests ELV001 doses against placebo in adults with active rheumatoid arthritis.
Baytown, United StatesAlso Boca Raton, Charlotte, Denver, Duncansville, Gilbert, Glendale, Houston, Jackson, …Age 18 to 75 - Tests BMS-986528 in adults with hard-to-treat rheumatoid arthritis
Tests the safety of BMS-986528 in adults with hard-to-treat rheumatoid arthritis.
Aurora, United StatesAlso Denver, DeSoto, La Jolla, Loma Linda, New York, Palo Alto, Philadelphia, Portland, …Age 18 to 65 - Tests stem cell infusions and joint injections for rheumatoid arthritis
Tests donor stem cells from umbilical cord or placenta in people with rheumatoid arthritis.
Naples, United States - First study of ABBV-519 in adults with lupus or rheumatoid arthritis
Tests ABBV-519 for safety in adults with lupus or rheumatoid arthritis.
Anniston, United StatesAlso Clearwater, Greenacres City, Houston, Jackson, Kissimmee, Miami, Orland Park, Plantation, …Age 18 to 75 - Tests AZD5492 safety in adults with lupus, myositis, or rheumatoid arthritis
Tests AZD5492, given under the skin, in adults with lupus, myositis, or arthritis.
Anniston, United StatesAlso Birmingham, Chapel Hill, Iowa City, La Jolla, Omaha, SacramentoAge 18 to 70 - Tests afimkibart against placebo in adults with rheumatoid arthritis
Tests afimkibart against placebo in adults with rheumatoid arthritis.
Avondale, United StatesAlso Chesapeake, Colleyville, Columbus, Detroit, Duncansville, Glendale, Houston, La Jolla, …Age 18+ - Long-term study of afimkibart in people with rheumatoid arthritis
Tests afimkibart over a longer time in adults with rheumatoid arthritis who took it before.
Glendale, United StatesAlso Houston, Lake Charles, Tamarac, TomballAge 18+ - BMS-986553 for Adults With Autoimmune Diseases That Have Not Responded to Treatment
Tests the safety of BMS-986553 in adults with hard-to-treat autoimmune diseases.
Ann Arbor, United StatesAlso Great Neck, Morristown, Newport Beach, Omaha, Philadelphia, Saint Paul, Salt Lake City, Seattle, …Age 18+ - Tests intravenous sarilumab in adults with rheumatoid arthritis
Tests intravenous sarilumab, with or without conventional DMARDs, in adults with rheumatoid arthritis.
Centennial, United StatesAlso Clearwater, Duncansville, El Paso, Hialeah, Hollywood, Houston, Mesquite, Miami, …Age 18+ - Tests AZD1163 in adults with moderately to severely active rheumatoid arthritis
Tests the drug AZD1163 against a placebo in adults with active rheumatoid arthritis.
Aurora, United StatesAlso Austin, Baltimore, Baytown, Boynton Beach, Glendale, Henderson, Houston, Jacksonville, …Age 18+ - Tests two new targeted drugs in adults with active rheumatoid arthritis
Tests lutikizumab and ravagalimab, alone or together, in adults with active rheumatoid arthritis.
Albuquerque, United StatesAlso Austin, Avon Park, Beverly Hills, Carrollton, Charlotte, Chicago, Chula Vista, Clearwater, …Age 18+ - Tests inebilizumab and blinatumomab in adults with lupus or refractory rheumatoid arthritis
Tests inebilizumab and blinatumomab in adults with active lupus or rheumatoid arthritis.
Aurora, United StatesAlso Boston, Cleveland, Great Neck, Hawthorne, Hialeah, Homestead, Houston, Miami, …Age 18 to 75 - Compares two drug switch options for rheumatoid arthritis not helped by TNF inhibitors
Compares two alternative drug classes in adults with active rheumatoid arthritis despite TNF inhibitor use.
Auburn, United StatesAlso Aventura, Baltimore, Birmingham, Boston, Brunswick, Carmel, Clearwater, Cleveland, …Age 18+ - FT839 for Several Autoimmune Diseases, Including Lupus and Rheumatoid Arthritis
Tests the safety of FT839 in adults with autoimmune diseases.
Fullerton, United StatesAge 18 to 70
Where treatment stands
There is no cure for rheumatoid arthritis, but early treatment can ease symptoms, slow the disease down and reduce joint damage.
Approved: 59
Officially approved for this disease in the EU, the US, Switzerland or France.
Human testing stage: 17
Being tested in people. Many treatments at this stage are never approved.
Animal testing stage: 4
Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.
Lab research stage: 1
Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.
Placebo: a dummy treatment without the medicine, used for comparison.
Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.
The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.
A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.
The trials: ClinicalTrials.gov and the EU trials register, as copied into our trial database, checked on 12 November 2026. Every treatment in trials links to its own trial records; the texts are written by AI from them and checked against them by a second AI. People have not reviewed them yet. Placebo, standard medicines used for comparison and procedures are left out.
Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 41 other open phase 2 trials are not listed.
Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for rheumatoid arthritis. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.
Not medical advice. Talk to your doctor before you change any treatment.
The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.
Support organisations
Patient organisations and helplines in United States, for you and your family.
Rheumatoid arthritis organisations in United States
- Arthritis Foundation
The largest US nonprofit dedicated to the prevention, control and cure of arthritis, with support and resources for RA, PsA, axial SpA and lupus.
- CreakyJoints
Patient community for people with arthritis and rheumatic disease (Global Healthy Living Foundation): support, education, advocacy and research.
- International Foundation for Autoimmune & Autoinflammatory Arthritis (AiArthritis)
US foundation for people with autoimmune and autoinflammatory arthritis, including RA, offering education, advocacy, research, podcasts and a patient community.
- Rheumatoid Arthritis Foundation, Help Fight RA
US 501(c)(3) nonprofit dedicated to rheumatoid arthritis, offering information, education, awareness events and support to RA patients.
General support in United States
- 988 Suicide & Crisis Lifeline
US national 24/7 free and confidential lifeline for anyone in suicidal crisis or emotional distress, reachable by calling or texting 988 or by chat.
- MedlinePlus
Free, easy-to-read health information service of the US National Library of Medicine (NIH) on diseases, conditions, drugs and wellness.
International organisations
Offer tissue or data
There are three ways to help research move faster.
Treatments approved outside the EU
Medicines for Rheumatoid arthritis approved in the US or Japan that are not approved in the EU.
Checked on 11 Nov 2026 in the official lists of the US (FDA), Japan (PMDA, approvals since April 2004) and the EU (EMA). 16 uncertain matches are left out.
Your health insurer may pay part of the cost, sometimes all of it. This depends on your insurer, your plan and the country, so always ask your insurer before you go. For planned care in the EU, the EEA and Switzerland, ask about form S2.
“Miracle cure” fact checker
Social media spreads misinformation. Paste what you read here, and we'll tell you whether there is scientific evidence behind it.
What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.
Before you pay for anything, ask three things
- Is there a published study in people?
- Can I have the full price in writing?
- What does my doctor say?
“Cures” others already fact-checked
- Omega-3 fatty acids (fish oil) & Rheumatoid arthritis
- Curcumin (turmeric) & Rheumatoid arthritis
- Stem cell treatment & Rheumatoid arthritis
- CBD (cannabidiol) & Rheumatoid arthritis
About Rheumatoid arthritis
A long-term condition in which the immune system attacks the lining of the joints by mistake, causing pain, swelling and stiffness.1 It often starts in the small joints of the hands and feet, usually on both sides of the body.2 There is no cure, but long-term medicines ease the symptoms and slow the disease down.1 Women get it more often than men, and with early treatment many people go months or years between flare-ups.1
What is it?
Rheumatoid arthritis is a long-term condition that causes pain, swelling and stiffness in the joints, most often the hands, feet and wrists.1 It is an autoimmune disease: the immune system, which normally fights infection, attacks the lining of the joints by mistake.1,3 Over time this can damage the joints, the cartilage and the bone nearby.1 It can also cause inflammation in other parts of the body, such as the eyes, lungs and heart.1,4
It can start at any age, but the risk goes up as people get older.4 It is more common in women than in men.3,4 It can run in families, but genes seem to play only a small part.3 Smoking may raise the risk.3,4 What sets it off is not known.3
The first signs
The signs usually come on slowly over a few weeks, sometimes over a few days.2 The small joints of the hands and feet are often affected first, usually on both sides of the body.2
- a throbbing, aching pain in the joints;2
- stiff joints, often worse in the morning or after resting, and often lasting longer than 30 minutes;2
- joints that are swollen, warm and tender;2
- feeling tired and low on energy;2
- a high temperature, sweating, poor appetite or weight loss.2
Some people get firm lumps under the skin near the affected joints.2,4 The signs can come and go, with flare-ups when they get worse.2,1
How doctors find out
There is no single test that proves it.4,5 Your family doctor checks your joints for swelling and how well they move, and asks about all your symptoms, even small ones.5 If it could be rheumatoid arthritis, you are sent to a joint specialist (rheumatologist).5,4 Blood tests look for signs of inflammation and for certain antibodies, such as rheumatoid factor and anti-CCP, that many people with the condition have.5 X-rays or an MRI scan show inflammation and damage in the joints.5
Current treatment
Treatment usually starts with methotrexate, often with another DMARD and a short course of steroids, and biological medicines or JAK inhibitors are added when these are not enough.Source: NHS
Will it get worse?
It is different for everyone, and the signs can come and go or change over time.2,4 With early diagnosis and the right treatment, many people go months or even years between flare-ups and can lead full lives.1 Keeping it well controlled lowers the risk of problems elsewhere in the body, such as inflammation in the lungs, heart or eyes, and a higher risk of heart attack and stroke.1
Medicines: what helps, and what to watch for
Disease-modifying medicines (DMARDs) are the main treatment.6 They calm the immune attack on the joints, which slows the damage and eases the symptoms.6 Methotrexate is usually the first, often with another DMARD and a short course of steroids.6 If these are not enough, biological medicines (given by injection) or JAK inhibitors can be added.6
Good to know:
- DMARDs can take a few months to work, so keep taking them even if you do not feel better at first;6,7
- Methotrexate can affect your blood cells and liver, so you will have regular blood tests. Less often it can affect the lungs, so you may have a chest X-ray when you start taking it.6
- side effects of methotrexate can include feeling sick, a sore mouth, diarrhoea, headaches and hair loss;6
- biological medicines can wake up old infections such as tuberculosis (TB);6
- steroids used for a long time can cause weight gain, weaker bones, easy bruising and thin skin;6
Exercise and therapy help too
- regular exercise keeps joints moving and muscles strong; swimming, cycling, walking and water aerobics are gentler on the joints than running or football;7
- balance rest and activity, and rest if a joint becomes warm, swollen or very painful;7
- a physiotherapist helps with fitness, strength and flexibility, and can use heat or ice packs;6
- an occupational therapist shows you how to protect your joints at home and at work, and can suggest splints and aids;6
- a foot specialist (podiatrist) can help with foot problems and insoles;6
- no special diet is proven to help, but a balanced, Mediterranean-style diet is recommended.6
Surgery, for some people
If joints are damaged despite medicines, surgery can ease pain or correct their shape.6 Options include operations on the hand and wrist, keyhole surgery to remove inflamed tissue from a joint, and replacing a hip, knee or shoulder.6 A joint replacement is a big operation, and recovery takes months.6
Is there a cure?
There is no cure for rheumatoid arthritis.1,4 Treatment aims to control the symptoms and limit damage to the joints, and starting it early helps most.4,1
Sources
Written in plain words by Frontlight from these pages: